Atlas Trials

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

Clinical trial NCT00472043 · COMPLETED

Trial details

NCT number
NCT00472043
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Basal Cell Carcinoma
Start date
2000-10-01
Primary completion
2002-09-30
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.